Dark

JAZZ
Jazz Pharmaceuticals, Inc.
stock NASDAQ

At Close

May 9, 2025 3:59:57 PM EDT

97.80USD-0.620%(-0.61)1,217,241

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 8, 2025 9:02:30 AM EDT

102.95USD+4.613%(+4.54)0

After-hours

May 9, 2025 4:13:30 PM EDT

97.45USD-0.358%(-0.35)13,491

OverviewOptionsHistoricalExchangesShortsNews

Jan 28, 2022

04:27PM EST The "Cannabis 50" List For 2021 Is Out, Is Your Favorite Company On It? Benzinga

Jan 14, 2022

04:08PM EST Report: Global Cannabis Beverages Market Expected To Reach $2B By 2026 Benzinga

Jan 10, 2022

08:11AM EST Jazz Pharma Announces $5 Bln Revenue Target For 2025 RTTNews

07:34AM EST Jazz Pharmaceuticals Announces 'Vision 2025'; Expects $5B In Revenue In 2025, Approval Of At least Five Additional Products By End Of Decade And 5% Adj. Operating Margin From 2021 To 2025 Benzinga

07:31AM EST Enhanced Value to Drive Transformation to Innovative, Global Biopharmaceutical Leader PR Newswire

Jan 5, 2022

08:15AM EST Jazz Pharma Publishes Full Data Set From Phase 3 Trial In RTTNews

07:48AM EST Jazz : Lancet Neurology Publishes Positive, Phase 3 Data Of Xywav Oral Solution For Idiopathic Hypersomnia RTTNews

07:46AM EST Jazz Pharmaceuticals Highlights Publication Of Pivotal Phase 3 Data Of Xywav In The Lancet Neurology Benzinga

07:45AM EST magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia PR Newswire

Jan 4, 2022

08:11AM EST The Daily Biotech Pulse: Liquidia Jumps On New CEO Appointment, Spectrum, Aravive Secure New Funding, Allena To Explore Strategic Alternatives Benzinga

06:07AM EST A Peek Into The Markets: US Stock Futures Up Ahead Of Manufacturing Report Benzinga

Jan 3, 2022

04:16PM EST Jazz Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare PR Newswire

04:12PM EST Jazz Announces FDA Orphan Drug Exclusivity Granted For Xywav Oral Solution Benzinga

04:10PM EST potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia in Adults PR Newswire

11:19AM EST Ten Biggest Weed Stories Of 2021: Big Pharma, Delta-8, Tech, Silicon Valley, MSOs, Politics And More Benzinga

Dec 30, 2021

01:11PM EST Jazz Pharmaceuticals Begins Enrollment For Clinical Trial To Evaluate JZP150 For Adults With PTSD Benzinga

08:13AM EST Jazz Pharmaceuticals: Debt Overview Benzinga

08:04AM EST Jazz Pharmaceuticals plc (JAZZ) announced Thursday that the first patient has been enrolled in a Phase 2 clinical trial evaluating the safety and efficacy of JZP150, an investigational first-in-class small molecule for the treatment of adults with post-traumatic stress disorder (PTSD). RTTNews

07:49AM EST Jazz Pharmaceuticals Announces First Patient Enrolled In Phase 2 Clinical Trial Evaluating JZP150 For Once-Daily Treatment Of Adults With Post-Traumatic Stress Disorder Benzinga

07:47AM EST Jazz : First Patient Enrolled In Phase 2 Trial Of JZP150 For Treatment Of Post-Traumatic Stress Disorder RTTNews

07:45AM EST Evaluating JZP150 for Once-Daily Treatment of Adults with Post-Traumatic Stress Disorder PR Newswire

Dec 23, 2021

09:07AM EST Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table Benzinga

Dec 20, 2021

09:42AM EST Analyst Ratings For Jazz Pharmaceuticals Benzinga

07:25AM EST A Look Into Jazz Pharmaceuticals Debt Benzinga

07:19AM EST 10 Biggest Price Target Changes For Monday Benzinga

04:53AM EST SVB Leerink Maintains Outperform on Jazz Pharmaceuticals, Lowers Price Target to $200 Benzinga

Dec 17, 2021

04:16PM EST The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More Benzinga

07:22AM EST 10 Biggest Price Target Changes For Friday Benzinga

06:07AM EST Needham Maintains Buy on Jazz Pharmaceuticals, Lowers Price Target to $215 Benzinga

Dec 15, 2021

07:51AM EST Jazz Announces First Patient Enrolled In Phase 2b Trial Of Suvecaltamide On Essential Tremor RTTNews

07:48AM EST Jazz Pharmaceuticals Announces First Patient Enrolled In Phase 2b Clinical Trial Evaluating Novel Suvecaltamide For Once-Daily Treatment Of Adults With Essential Tremor Benzinga

07:46AM EST Trial Evaluating Novel Suvecaltamide (JZP385) for Once-Daily Treatment of Adults with Essential Tremor PR Newswire

Dec 13, 2021

11:44AM EST How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal Benzinga

09:26AM EST Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting Benzinga

06:06AM EST PharmaMar, Jazz Pharmaceuticals Announced Initiation of Confirmatory Phase 3 Clinical Trial of Zepzelca (lurbinectedin) for the Treatment of Patients with Relapsed Small Cell Lung Cancer Benzinga

02:36AM EST Jazz Pharma Initiates Phase 3 Trial Of Zepzelca For Treatment Of Patients With Relapsed Small Cell Lung Cancer RTTNews

02:30AM EST Clinical Trial of Zepzelca(r) (lurbinectedin) for the Treatment of Patients with Relapsed Small Cell Lung Cancer PR Newswire

Dec 12, 2021

09:40AM EST Jazz Pharmaceuticals Presented Interim Phase 2/3 Results of Rylaze in Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma at ASH 2021; Said Rylaze Maintains Clinically Meaningful Level of Asparaginase Activity Throughout the Entire Duration of Treatment Benzinga

09:04AM EST Jazz Pharma Presents Positive Interim Phase 2/3 Results Of Rylaze In ALL Or Lymphoblastic Lymphoma At ASH RTTNews

09:00AM EST (asparaginase erwinia chrysanthemi (recombinant)-rywn) in Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma at ASH 2021 Annual Meeting PR Newswire

Dec 9, 2021

09:44PM EST Redx to Receive Milestone Payment of $10m from Jazz Benzinga

Dec 1, 2021

07:47AM EST Jazz To Present From Expanding Neuroscience Portfolio Epidiolex Oral Solution Data RTTNews

07:46AM EST Jazz Pharmaceuticals To Present From Expanding Neuroscience Portfolio Epidiolex Oral Solution Data At 2021 American Epilepsy Society Annual Meeting Dec. 3-7 Benzinga

07:45AM EST Epidiolex(r) (cannabidiol) Oral Solution Data at the 2021 American Epilepsy Society Annual Meeting PR Newswire

Nov 30, 2021

04:44PM EST Jazz Pharmaceuticals Announces First Patient Enrolled In IMforte Phase 3 Trial Evaluating Zepzelca In Combination With A PD-L1 Inhibitor In Small Cell Lung Cancer Benzinga

04:44PM EST Jazz Pharmaceuticals Announces Commercial Availability In Canada Of Zepzelca Benzinga

08:11AM EST Jazz : First Patient Enrolled In IMforte Phase 3 Trial Evaluating Zepzelca In Combination With A PD-L1 Inhibitor In SCLC RTTNews

08:10AM EST Jazz Pharmaceuticals plc (JAZZ) announced the commercial availability in Canada of Zepzelca (lurbinectedin), the first new treatment in Canada for adult patients with stage III or metastatic small cell lung cancer who have progressed on or after platinum-containing therapy in more than a decade. RTTNews

08:02AM EST Evaluating Zepzelca(r) (lurbinectedin) in Combination with a PD-L1 Inhibitor in Small Cell Lung Cancer PR Newswire

07:48AM EST Jazz Announces Commercial Availability In Canada Of Zepzelca, New Treatment For Metastatic Small Cell Lung Cancer RTTNews

07:45AM EST Zepzelca(tm) (lurbinectedin), the First New Treatment for Stage III or Metastatic Small Cell Lung Cancer in More Than a Decade PR Newswire

Nov 9, 2021

06:54PM EST Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance Benzinga

05:05PM EST Jazz Pharmaceuticals: Q3 Earnings Insights Benzinga

04:45PM EST Jazz Pharmaceuticals Narrows FY21 Guidance From $3.02B-$3.18B To $3.02B-$3.1B Benzinga

04:37PM EST Jazz Pharmaceuticals Q3 EPS $4.20 Beats $3.31 Estimate, Sales $838.12M Beat $832.52M Estimate Benzinga

04:16PM EST Jazz Pharmaceuticals to Participate in Upcoming November Investor Conferences PR Newswire

04:06PM EST Jazz Pharmaceuticals Announces Third Quarter 2021 Financial Results And Raises PR Newswire

11:42AM EST The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Benzinga

11:25AM EST Earnings Scheduled For November 9, 2021 Benzinga

Nov 8, 2021

08:29AM EST The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More Benzinga

Nov 4, 2021

11:07AM EDT Jazz Pharmaceuticals To Present Data Showcasing Clinical Advances Across Hematology/Oncology At ASH 2021 Annual Meeting Benzinga

11:05AM EDT Jazz Pharmaceuticals to Present Data Showcasing Clinical Advances Across PR Newswire

Nov 2, 2021

10:54AM EDT The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US Benzinga

Oct 26, 2021

04:16PM EDT Jazz Pharmaceuticals to Report 2021 Third Quarter Financial Results on November PR Newswire

Oct 8, 2021

08:00AM EDT Morgan Stanley Maintains Equal-Weight on Jazz Pharmaceuticals, Lowers Price Target to $174 Benzinga

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Oct 5, 2021

10:14AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021 Benzinga

08:42AM EDT Citigroup Initiates Coverage On Jazz Pharmaceuticals with Buy Rating, Announces Price Target of $200 Benzinga

08:01AM EDT The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout Benzinga

Oct 1, 2021

01:51PM EDT SEC Charges Former Goldman Sachs Officer For Insider Trading On 2 M&A Deals Benzinga

Sep 23, 2021

10:06AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021 Benzinga

04:49AM EDT Needham Initiates Coverage On Jazz Pharmaceuticals with Buy Rating, Announces Price Target of $220 Benzinga

Sep 22, 2021

10:18AM EDT Grove's Acquisitions Fueling Company's Growth Benzinga

07:45AM EDT The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs Benzinga

Sep 17, 2021

07:36AM EDT The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold Benzinga

Sep 13, 2021

04:16PM EDT Jazz Pharmaceuticals Announces Xywav Investor Webcast On Oct. 13, 2021 Benzinga

04:16PM EDT Jazz Pharmaceuticals Announces Xywav(r) (calcium, magnesium, potassium, and PR Newswire

Sep 8, 2021

04:16PM EDT Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences PR Newswire

11:58AM EDT Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach 1.8 Billion By 2025 Benzinga

Aug 31, 2021

11:47AM EDT Canada Approves Jazz Pharma's Excessive Daytime Sleepiness Med Benzinga

08:11AM EDT Jazz Pharma Announces Health Canada Approval Of Sunosi - RTTNews

08:04AM EDT Jazz : Canada Approves Sunosi For Excessive Daytime Sleepiness Associated With Narcolepsy Or Obstructive Sleep Apnea RTTNews

08:02AM EDT Jazz Pharma Reports Health Canada Approval Of Sunosi for Excessive Daytime Sleepiness Related To Narcolepsy, Obstructive Sleep Apnea Benzinga

Aug 20, 2021

01:39PM EDT Return on Capital Employed Insights for Jazz Pharmaceuticals Benzinga

Aug 16, 2021

07:57AM EDT 10 Biggest Price Target Changes For Monday Benzinga

06:37AM EDT HC Wainwright & Co. Maintains Buy on Jazz Pharmaceuticals, Lowers Price Target to $210 Benzinga

Aug 15, 2021

12:16PM EDT The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow Benzinga

11:06AM EDT The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow Benzinga

Aug 13, 2021

07:43AM EDT The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO Benzinga

Aug 12, 2021

02:30PM EDT Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia in Adults Benzinga

02:30PM EDT magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia in Adults PR Newswire

08:09AM EDT The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma Benzinga

Aug 10, 2021

02:59PM EDT GW Pharmaceuticals' Cannabidiol For Seizures Wins UK Approval Benzinga

08:02AM EDT Stand Up To Cancer And Jazz Pharmaceuticals Announce A 3-Year, $4M Research Collaboration To Fund Catalyst Research On Hard-To-Treat Cancers Benzinga

08:01AM EDT Stand Up To Cancer And Jazz Pharmaceuticals Collaborate To Fund Catalyst PR Newswire

05:54AM EDT Jazz Pharmaceuticals' GW Pharmaceuticals Received UK Approval for EPIDYOLEX for the Treatment of Seizures Associated with Tuberous Sclerosis Complex Benzinga

04:28AM EDT GW Pharma Gets Approval For EPIDYOLEX From MHRA For Seizures Associated With Tuberous Sclerosis Complex RTTNews

04:25AM EDT MHRA for the treatment of seizures associated with tuberous sclerosis complex PR Newswire

Aug 9, 2021

11:07AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

09:00AM EDT Benzinga Pro's Top 5 Stocks To Watch For Monday, Aug. 9, 2021: DKNG, AMC, PDAC, JAZZ, VUZI Benzinga

Aug 8, 2021

10:11AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

Aug 6, 2021

10:51AM EDT Watch Medical Marijuana & Unrivaled Brands At The Benzinga Cannabis Hour Benzinga

Aug 3, 2021

05:33PM EDT Recap: Jazz Pharmaceuticals Q2 Earnings Benzinga

04:14PM EDT Jazz Pharmaceuticals Sees FY21 Sales $3.02B-$3.18B Vs. $3.11B Est., EPS $13.40-$14.70 Vs. $14.45 Est. Benzinga

04:13PM EDT Jazz Pharmaceuticals Q2 EPS $3.90 Beats $3.42 Estimate, Sales $751.81M Beat $735.62M Estimate Benzinga

04:06PM EDT Jazz Pharmaceuticals Announces Second Quarter 2021 Financial Results PR Newswire

03:52AM EDT Earnings Scheduled For August 3, 2021 Benzinga

Aug 2, 2021

06:10PM EDT Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates Benzinga

10:59AM EDT Jazz Pharmaceuticals's Earnings: A Preview Benzinga

Jul 29, 2021

02:04PM EDT Does Big Business Provide A Better Look Into Cannabis Reform Than Capitol Hill? Operators Believe So. Benzinga

06:17AM EDT Jazz Pharmaceuticals Says on July 28, 2021, Filed a Patent Infringement Suit Against Lupin Inc in U.S. District Court for District of New Jersey Alleging That by Filing Its ANDA, Lupin Has Infringed Ten of Company's Orange Book Listed Patents Benzinga

Jul 22, 2021

04:53PM EDT NCCN Adds Rylaze To Clinical Practice Guidelines In Oncology For Acute Lymphoblastic Leukemia RTTNews

04:16PM EDT Jazz Pharma Reports National Comprehensive Cancer Network Adds Co.'s Newly-Approved Rylaze To Clinical Practice Guidelines In Oncology For Acute Lymphoblastic Leukemia Benzinga

04:16PM EDT (asparaginase erwinia chrysanthemi (recombinant)-rywn) to Clinical Practice Guidelines in Oncology for Acute Lymphoblastic Leukemia PR Newswire

Jul 21, 2021

09:16AM EDT Ligand Partner Jazz Pharmaceuticals Launches RYLAZE; Ligand Expects To Receive $7M In Milestone Payments Benzinga

Jul 20, 2021

04:16PM EDT Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August PR Newswire

Jul 14, 2021

12:42PM EDT Senate Majority Leader Schumer Says Put A Lot Of Work Into Bill, Says Will Seek Feedback From Colleagues; Says Will Work On Getting Something Done Benzinga

12:38PM EDT Oregon Senator Ron Wyden Says Revenue Generated From Legalizing Cannabis Will Go To Restoration Of Lives Of Those Affected By War On Drugs Benzinga

12:35PM EDT New Jersey Senator Cory Booker Says 'This Is A Historic Day', Highlights Importance Of High-Ranking Officials Leading Charge On Cannabis Reform Benzinga

Jul 13, 2021

04:16PM EDT Jazz Pharmaceuticals Announces Rylaze Chrysanthemi Investor Webcast On July 20, 2021 Benzinga

04:16PM EDT Jazz Pharmaceuticals Announces Rylaze(tm) (asparaginase erwinia chrysanthemi PR Newswire

Jul 7, 2021

08:02AM EDT Jazz Pharmaceuticals plc (JAZZ) said that the Health Canada has approved Vyxeos -daunorubicin and cytarabine liposome for injection- for the treatment of adults with newly diagnosed therapy-related AML (t-AML) or AML with myelodysplasia-related changes or AML-MRC. RTTNews

07:48AM EDT Jazz Pharma: Health Canada Approves Vyxeos For Adults With High-risk Acute Myeloid Leukemia RTTNews

07:46AM EDT Jazz Pharmaceuticals Announces Health Canada Approval Of Vyxeos Benzinga

07:45AM EDT Health Canada Approves Vyxeos(r), the First Chemotherapy Advance in over 40 PR Newswire

Jul 6, 2021

06:18PM EDT Horizons ETFs Rebalances Marijuana-Focused Index Etfs PR Newswire

04:04PM EDT The Week In Cannabis: Justice Clarence Thomas, Mexico's Decriminalization, Apple's Policy Changes, Tilray And More Benzinga

Jul 2, 2021

12:42PM EDT Global Cannabis Stocks Decline 8.7% in Q2, Agrify, KushCo Among Strongest Cannabis Names In June Benzinga

Jul 1, 2021

08:07AM EDT The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts Benzinga

06:40AM EDT Jazz Pharma's Rylaze Scores FDA Approval For Blood Cancer Benzinga

Jun 30, 2021

09:33PM EDT FDA Approves Jazz's Rylaze To Treat Acute Lymphoblastic RTTNews

08:05PM EDT erwinia chrysanthemi (recombinant)-rywn) for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma PR Newswire

Jun 25, 2021

08:07AM EDT Jazz Pharmaceuticals plc (JAZZ) said Friday that the U.S. Food and Drug Administration has recognized seven years of Orphan Drug Exclusivity for Xywav--calcium, magnesium, potassium, and sodium oxybates-- oral solution for the treatment of cataplexy or excessive daytime sleepiness or EDS in patients 7 years of age and older with narcolepsy. RTTNews

07:55AM EDT Jazz Says FDA Recognized Seven Years Of Orphan Drug Exclusivity For Xywav Oral Solution RTTNews

07:45AM EDT Jazz Pharmaceuticals Announces FDA Orphan Drug Exclusivity For Xywav Oral Solution Benzinga

07:45AM EDT Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav(tm) (calcium, PR Newswire

Jun 24, 2021

08:43AM EDT New Cannabinoid-Based Drug Candidates from Artelo Biosciences Show Promise as Cancer and Mental Health Treatments; Key Data Due Before Year End Benzinga

Jun 23, 2021

07:21AM EDT Jazz Pharmaceuticals on June 22 Received FDA Orphan Drug Designation for their Treatment of Acute Lymphoblastic Leukemia Benzinga

07:19AM EDT Jazz Pharmaceuticals on June 22 Received FDA Orphan for their Treatment of Acute Lymphoblastic Leukemia Benzinga

Jun 22, 2021

11:50AM EDT Where Jazz Pharmaceuticals Stands With Analysts Benzinga

07:40AM EDT 10 Biggest Price Target Changes For Tuesday Benzinga

07:11AM EDT Barclays Maintains Overweight on Jazz Pharmaceuticals, Raises Price Target to $250 Benzinga

Jun 21, 2021

07:53AM EDT 10 Biggest Price Target Changes For Monday Benzinga

06:23AM EDT HC Wainwright & Co. Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $220 Benzinga

Jun 18, 2021

07:40AM EDT 10 Biggest Price Target Changes For Friday Benzinga

06:17AM EDT SVB Leerink Maintains Outperform on Jazz Pharmaceuticals, Raises Price Target to $230 Benzinga

Jun 17, 2021

08:33AM EDT Jazz Pharmaceuticals Updates 2021 Guidance To Include GW Pharma Acquisition Benzinga

07:56AM EDT Jazz Pharmaceuticals plc (JAZZ) updated its full year 2021 financial guidance to incorporate the GW Pharmaceuticals business, which the company acquired on May 5, 2021. RTTNews

07:38AM EDT Jazz Pharmaceuticals Now Sees 2021 Total Revenue To Range Of $3.02 Bln-$3.18 Bln RTTNews

07:33AM EDT Jazz Pharmaceuticals Updates 2021 Financial Guidance To Include Recently Acquired GW Pharmaceuticals plc; Co. Now Sees FY21 Adj. EPS $13.40-$14.70 vs $15.05 Est., Sales $3.02B-$3.18B vs $3.11B Est. Benzinga

07:31AM EDT Jazz Pharmaceuticals Updates 2021 Financial Guidance to Include Recently PR Newswire

Jun 16, 2021

08:20AM EDT The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO Benzinga

Jun 15, 2021

08:07AM EDT The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda Benzinga

Jun 14, 2021

07:30AM EDT First and Only Digital Hub Focused Exclusively on Emotional, Social and Physical Health Needs of Small Cell Lung Cancer Community PR Newswire

Jun 11, 2021

08:05AM EDT The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts Benzinga

Jun 10, 2021

08:13AM EDT The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal Benzinga

Jun 9, 2021

03:02PM EDT Cannabis Investors Discuss Strategies For 2021 In The Context Of Consolidation And Interstate Commerce Benzinga

07:47AM EDT Jazz Pharmaceuticals To Present 18 abstracts At SLEEP 2021 Jun. 10-13 Benzinga

07:45AM EDT Jazz Pharmaceuticals Presents 18 Abstracts in Sleep Medicine at SLEEP 2021 PR Newswire

May 26, 2021

04:16PM EDT Jazz Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference PR Newswire

May 25, 2021

07:53AM EDT The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal Benzinga

May 20, 2021

07:47AM EDT Jazz To Present Data At ASCO And EHA 2021 Meetings Benzinga

07:45AM EDT Jazz to Present New Data at ASCO and EHA 2021 Meetings Showcasing Clinical PR Newswire

May 17, 2021

08:11AM EDT 10 Biggest Price Target Changes For Monday Benzinga

06:12AM EDT HC Wainwright & Co. Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $212 Benzinga

May 14, 2021

07:49AM EDT Cramer Advises Viewers On Suncor, Jazz And More Benzinga

May 13, 2021

08:10AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use Benzinga

May 11, 2021

12:38PM EDT The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More Benzinga

May 6, 2021

10:45AM EDT Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio Benzinga

May 5, 2021

09:27AM EDT Jazz Pharma Completes Acquisition Of GW Pharma RTTNews

09:27AM EDT Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc PR Newswire

May 4, 2021

04:50PM EDT Jazz Pharmaceuticals Sees FY21 Sales $2.55B-$2.70B Vs. $2.65B Est. Benzinga

04:49PM EDT Jazz Pharmaceuticals Q1 EPS $3.92 Beats $3.74 Estimate, Sales $607.58M Miss $611.49M Estimate Benzinga

04:16PM EDT Jazz Pharmaceuticals to Participate in Three Investor Conferences in May 2021 PR Newswire

04:06PM EDT Jazz Pharmaceuticals Announces First Quarter 2021 Financial Results PR Newswire

08:10AM EDT The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data Benzinga

Apr 29, 2021

04:06PM EDT Jazz Pharmaceuticals Announces Closing of Senior Secured Notes Offering PR Newswire

Apr 23, 2021

04:02PM EDT GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals Benzinga

04:01PM EDT GW Pharmaceuticals Shareholders Approve Acquisition by Jazz GlobeNewswire Inc

Apr 22, 2021

05:02PM EDT Jazz Pharmaceuticals Prices $1.5 Billion Senior Secured Notes Offering PR Newswire

Apr 20, 2021

10:49AM EDT Novel Approach to Cancer From Lixte Biotechnology Could Be a General way to Enhance a Variety of Standard Treatments Benzinga

09:21AM EDT Jazz Pharmaceuticals Plc Says For March Quarter, Co. Estimates Revenues $605M-$610M Representing Increase Of About 13% To 14%; Sees Adj. EBITDA $303M-$307M Benzinga

08:45AM EDT Jazz Pharmaceuticals Announces Proposed Private Offering of Senior Secured Notes PR Newswire

07:53AM EDT Jazz Pharma Presents Phase 3 Study Results Of Xywav Oral Solution In Adult Patients With Idiopathic Hypersomnia At AAN RTTNews

07:48AM EDT Jazz Pharmaceuticals Announced Presentation of Phase 3 Study Results of Xywav Oral Solution in Adult Patients with Idiopathic Hypersomnia at 2021 American Academy of Neurology Annual Meeting; Says Xywav Demonstrated Statistically Significant Differences in Change in Epworth Sleepiness Scale Score Benzinga

07:45AM EDT magnesium, potassium, and sodium oxybates) Oral Solution in Adult Patients with Idiopathic Hypersomnia at 2021 American Academy of Neurology Annual Meeting PR Newswire

Apr 19, 2021

04:05PM EDT Jazz Pharmaceuticals to Report 2021 First Quarter Financial Results on May 4, PR Newswire

Apr 14, 2021

10:13AM EDT Stifel Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $202 Benzinga

Apr 12, 2021

07:55AM EDT Jazz Pharma Announces FDA Acceptance And Priority Review Of SNDA For Xywav Oral Solution In Idiopathic Hypersomnia RTTNews

07:47AM EDT Jazz Pharmaceuticals Announces FDA Acceptance And Priority Review Of Supplemental New Drug Application For Xywav Oral Solution In Idiopathic Hypersomnia Benzinga

07:45AM EDT Supplemental New Drug Application for Xywav(tm) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution in Idiopathic Hypersomnia PR Newswire

Apr 8, 2021

04:28PM EDT Codiak BioSciences And Jazz Pharmaceuticals On Apr. 2 Mutually Agreed To Discontinue Work On Mutually exoASO-STAT3; Companies Will Continue To Jointly Advance Their R&D Efforts On Other Exosome-Based Therapeutic Programs Benzinga

Apr 5, 2021

06:00AM EDT Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, today announced the appointment of an additional member to its Board of Directors. GlobeNewswire Inc

Apr 1, 2021

09:37AM EDT Morgan Stanley Maintains Equal-Weight on Jazz Pharmaceuticals, Raises Price Target to $176 Benzinga

Mar 31, 2021

07:41AM EDT The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO Benzinga

Mar 30, 2021

06:15PM EDT Vyxeos(r) (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients PR Newswire

09:37AM EDT Jazz Pharmaceuticals Shares See Volume; Co Granted U.S. Patent Titled 'Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances' Benzinga

Mar 23, 2021

01:25PM EDT Samantha Gleit Behind Debt Structure In Today's Cannabis Industry Benzinga

Mar 22, 2021

04:06PM EDT Jazz Pharmaceuticals Announces Participation at the 10th Annual J.P. Morgan PR Newswire

Mar 18, 2021

07:45AM EDT Jazz Pharmaceuticals and Hypersomnia Foundation Launch Campaign to Increase PR Newswire

Mar 5, 2021

03:02PM EST Driven By Stem, a Vertically Integrated, Farm-to-Home, DaaS Platform Upticking the Future of the Cannabis Industry in 2021 Benzinga

09:30AM EST Driven By Stem Is A DaaS Platform Designed For The Future Of The Cannabis Industry Benzinga

Mar 1, 2021

11:38AM EST UBS Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $228 Benzinga

Feb 26, 2021

10:06AM EST Item 9 Labs and Why Franchising is the Growth Vehicle to Propel the Cannabis Industry Benzinga

Feb 25, 2021

08:08AM EST The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants Benzinga

Feb 24, 2021

09:40AM EST Piper Sandler Maintains Overweight on Jazz Pharmaceuticals, Raises Price Target to $205 Benzinga

05:19AM EST SVB Leerink Maintains Outperform on Jazz Pharmaceuticals, Lowers Price Target to $210 Benzinga

Feb 23, 2021

04:24PM EST Recap: Jazz Pharmaceuticals Q4 Earnings Benzinga

04:10PM EST Jazz Pharmaceuticals Announces Participation at Cowen 41st Annual Healthcare PR Newswire

04:07PM EST Jazz Pharma Sees FY21 Sales $2.55B-$2.7B vs $2.56B Estimate, Adj. EPS $15.65-$16.85 vs $16.78 Estimate Benzinga

04:06PM EST Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2020 Financial PR Newswire

04:06PM EST Jazz Pharmaceuticals Q4 Adj. EPS $4.00 Misses $4.20 Estimate, Sales $665.52M Beat $639.55M Estimate Benzinga

07:25AM EST The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts Benzinga

04:09AM EST Earnings Scheduled For February 23, 2021 Benzinga

Feb 22, 2021

05:14PM EST Cannabis Industry Set For More Consolidations In 2021 Benzinga

10:21AM EST Preview: Jazz Pharmaceuticals's Earnings Benzinga

Feb 17, 2021

04:06PM EST Jazz Pharmaceuticals Announces Participation in the Leerink 10th Annual Global PR Newswire

Feb 16, 2021

07:57AM EST Jazz Pharmaceuticals Completes Submission Of SNDA For Xywav Oral Solution For Idiopathic Hypersomnia RTTNews

07:46AM EST Jazz Pharmaceuticals Completes Submission Of Supplemental New Drug Application For Xywav Oral Solution For Idiopathic Hypersomnia Benzinga

07:45AM EST for Xywav(tm) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia PR Newswire

07:19AM EST GW Pharmaceuticals Q4 EPS $(0.08) Down From $(0.07) YoY, Sales $148.20M Up From $109.08M YoY Benzinga

07:00AM EST Total revenue of $148.2 million for the fourth quarter and $527.2 million for the full year GlobeNewswire Inc

Feb 10, 2021

04:23PM EST The Week In Cannabis: Stocks Up By Double-Digits On Jazz Pharma's GWPH Acquisition, Potential Federal Moves Benzinga

07:34AM EST The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs Benzinga

Feb 9, 2021

04:06PM EST Jazz Pharmaceuticals to Report 2020 Fourth Quarter Financial Results on PR Newswire

Feb 7, 2021

12:00PM EST Lifshitz Law Firm, P.C. Announces Investigation of CNIG, GWPH, JAZZ, HOL, JWS, PR Newswire

Feb 6, 2021

12:42PM EST The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight Benzinga

Feb 5, 2021

04:21PM EST The Week In Cannabis: Stocks Up By Double-Digits On Jazz Pharma's GWPH Acquisition, Potential Federal Moves Benzinga

09:26AM EST HC Wainwright & Co. Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $207 Benzinga

Feb 4, 2021

07:22AM EST The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs Benzinga

Feb 3, 2021

05:33PM EST SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of GlobeNewswire Inc

04:46PM EST SHAREHOLDER ALERT: WeissLaw LLP Investigates GW Pharmaceuticals plc PR Newswire

12:15PM EST Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of GW Pharmaceuticals plc (NASDAQ: GWPH) breached their fiduciary duties or violated the federal securities laws in connection with the companys acquisition by Jazz Pharmaceuticals plc (NASDAQ: JAZZ). GlobeNewswire Inc

09:07AM EST Zogenix Shares Up 21% In Sympathy Following Jazz Pharma/GW Pharma Deal; Mizuho Says Deal Has 'Positive Read Through' To Zogenix; Firm Maintains Buy Rating, $55 Price Target On Zogenix Benzinga

08:30AM EST Alan Brochstein, The 420 Investor, Says On Benzinga's PreMarket Prep Says Thinks We're Going To See 'A Lot Of Development' In Cannabis Science; Highlight's GW Pharmaceuticals FDA Clearance Benzinga

08:10AM EST Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Feb. 3, 2021: FDX, TER, APHA, TAST, ARTL Benzinga

08:09AM EST Jazz To Acquire Cannabinoid Drug Company GW Pharma For $7.2B Benzinga

07:35AM EST Jazz To Acquire GW Pharmaceuticals For Total Consideration Of $7.2 Bln, Or $6.7 Bln Net Of GW Cash RTTNews

07:31AM EST UPDATE: Jazz To Buy GW Pharma For $200/Share In Cash, $20 In Jazz Shares For Total Consideration Of $7.2B Benzinga

07:31AM EST Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, PR Newswire

07:31AM EST Jazz Pharma To Buy GW Pharma For $220/ADS In Cash, Shares Benzinga

Jan 29, 2021

10:04AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 29, 2021 Benzinga

08:45AM EST Morgan Stanley Downgrades Jazz Pharmaceuticals to Equal-Weight, Lowers Price Target to $162 Benzinga

Jan 21, 2021

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

Jan 20, 2021

07:32AM EST The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study Benzinga

Jan 15, 2021

07:57AM EST The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges Benzinga

Jan 8, 2021

07:25AM EST The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs Benzinga

Jan 4, 2021

04:06PM EST Jazz Pharmaceuticals Announces Participation in the 39th Annual J.P. Morgan PR Newswire

Dec 29, 2020

08:09AM EST The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica Benzinga

Dec 21, 2020

08:30AM EST Jazz Pharma Initiates BLA Submission For JZP-458 For Treatment Of Acute Lymphoblastic Leukemia RTTNews